Version 2.78

Part Description

LP16715-2   HIV 1+2
Two types of human immunodeficiency viruses (HIV) have been characterized: HIV-1 and HIV-2. HIV-1 was initially discovered in the early 1980s and thought to be the sole causative agent of HIV infections and ultimately AIDS. In 1986, HIV-2 was isolated and also found to cause AIDs. HIV-1 is more virulent and the predominant cause of the HIV infections worldwide. HIV-2 is poorly transmitted and is primarily concentrated in West Africa.

Presently (2012), HIV-1 strains are divided into four groups, including group M (major) with subtypes A through K, group O (outlier), group N (non-M or O), and group P. HIV-2 is divided into subtypes A through E. Occasionally, two viruses of different subtypes can "cross react" and blend their genetic material to create a new hybrid HIV virus. However, many of these new strains do not survive for long. Studies have also shown that the core proteins of HIV-1 and HIV-2 display frequent cross-reactivity whereas the envelope proteins are more type-specific. Source: Regenstrief LOINC

Fully-Specified Name

Component
HIV 1+2 Ab.IgG
Property
PrThr
Time
Pt
System
Ser/Plas
Scale
Ord
Method
IA

Additional Names

Short Name
HIV1+2 IgG SerPl Ql IA
Display Name
HIV 1+2 IgG IA Ql
Consumer Name Alpha Get Info
HIV 1+2 IgG antibody, Blood

Basic Attributes

Class
MICRO
Type
Laboratory
First Released
Version 2.15
Last Updated
Version 2.73
Change Reason
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016.
Order vs. Observation
Both
Common Test Rank Get Info
13370

Member of these Panels

LOINC Long Common Name
75622-1 HIV 1 and 2 tests - Meaningful Use set

Language Variants Get Info

Tag Language Translation
de-DE German (Germany) HIV-1+2 Ak.IgG:Nachweis oder Schwellenwert:Zeitpunkt:Serum oder Plasma:Ordinal:Immunoassay
el-GR Greek (Greece) HIV 1+2 IgG ανοσοσφαιρίνη:PrThr:Χρονική στιγμή:Ορός/Πλάσμα:Τακτική:IA
Synonyms: Ab IgG
es-ES Spanish (Spain) VIH 1-2 IgG:PrThr:Punto temporal:Suero o Plasma:Ord:IA
es-MX Spanish (Mexico) VIH 1 + 2 Ab.IgG:Presencia o umbral:Punto temporal:Suero o Plasma:Ordinal:Inmunoensayo
et-EE Estonian (Estonia) HIV 1+2 antikehad.IgG:PrThr:Pt:S/P:Ord:IA
Synonyms: Immuunglobuliin G Inimese immuunpuudulikkuse viirus Inimese immuunpuudulikkuse viiruse 1. ja 2 tüüp Järgarvuline Juhuslik Plasma Seerum Seerum või plasma
fr-CA French (Canada) VIH 1+2, IgG:Présence-Seuil:Temps ponctuel:Sérum/Plasma:Ordinal:IA
fr-FR French (France) VIH-1+2 Ac IgG:Présence/Seuil:Ponctuel:Sérum/Plasma:Qualitatif:Immunoanalyse
fr-BE French (Belgium) VIH 1+2 Anticorps. IgG:PrThr:Temps ponctuel:Sérum/Plasma:Ordinal:IA
Synonyms: Anticorps HIV HIV 1 HIV 1&2 HIV 1+2
it-IT Italian (Italy) HIV 1+2 Ab.IgG:PrThr:Pt:Siero/Plasma:Ord:IA
Synonyms: anticorpi IgG anticorpo Immunoassay Microbiologia Plasma Presenza o Soglia Punto nel tempo (episodio) Siero Siero o Plasma
ko-KR Korean (Korea, Republic Of) 사람 면역결핍 바이러스 1+2 항체.면역글로불린 G:임의농도:검사시점:혈청:순위척도:효소면역측정법
nl-NL Dutch (Netherlands) HIV 1+2 As.IgG:aanwezigheid:moment:serum of plasma:ordinaal:immunoassay
Synonyms: antistof; antilichaam IA
pl-PL Polish (Poland) HIV 1+2 Ab.IgG:granica wykrywalności:punkt w czasie:surowica lub osocze:półilościowy:metoda immunologiczna
Synonyms: IgG Ludzki wirus niedoboru odporności typu 1 Ludzki wirus niedoboru odporności typu 1 i 2 Ludzki wirus niedoboru odporności typu 1+2 Przeciwciała do HIV 1 i 2 Przeciwciała do HIV 1+2 Przeciwciała IgG do HIV 1 i 2 Przeciwciała IgG do HIV 1+2
pt-BR Portuguese (Brazil) HIV 1+2 Ac.IgG:ACnc:Pt:Soro:Ord:Imunoensaio
Synonyms: Immune globulin G; Immunoglobulin G; HIV1+2; HIV1; HTLV III; HTLV 3; HIV type 1; HIV type I; AIDS; Human immunodeficiency virus; Arbitrary concentration; Point in time; Random; Serum; SR; Ql; Ordinal; QL; Qualitative; Qual; Screen; Enzyme immunoassay; ELISA; MEIA; SUDS; ELFA; IAA; Antibodies; Autoantibody; Antibody; Autoantibodies; Antby; Acy; Anti; II; Microbiology
ru-RU Russian (Russian Federation) HIV 1+2 Ат.IgG:PrThr:ТчкВрм:Сыв/Плаз:Пор:IA
Synonyms: Антитело ВИЧ ВИЧ 1 ВИЧ 1 и 2 ВИЧ 1+2 Плазма Порядковый Сыворотка Сыворотка или Плазма Точка во времени;Момент
tr-TR Turkish (Turkey) HIV 1+2 Ab.IgG:MevcEşik:Zmlı:Ser/Plaz:Srl:İA
Synonyms: Ak Ak.IgG İmmünölçüm, immünoassay Mevcut
zh-CN Chinese (China) HIV 1 型+2 型 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法
Synonyms: Ⅰ Ⅱ Ab.IgG;IgG;抗体 IgG Ab;自身抗体 AIDS;AIDS 病毒;人类免疫缺陷病毒;人类免疫缺陷病毒（Human immunodeficiency virus，HIV）;爱滋病;艾滋病;艾滋病病毒;获得性免疫缺陷综合征;获得性免疫缺陷综合征（Acquired Immure Deficiency Syndrome，AIDS，艾滋病） HIV 1 & 2 Ab HIV 1+2 Ab HIV 1+2 Ab.IgG HIV1;HTLV 3;HTLV III;人类免疫缺陷病毒 1 型;人类免疫缺陷病毒 I 型;HIV 1 型（人类免疫缺陷病毒 1 型、人类免疫缺陷病毒 I 型、人免疫缺陷病毒 1 型、人免疫缺陷病毒 I 型、HIV I、HIV I 型、艾滋病病毒 I 型） I II 人类免疫缺陷病毒 1 & 2 型 Ab 人类免疫缺陷病毒 1 & 2 型抗体 人类免疫缺陷病毒 1 与 2 型 Ab 人类免疫缺陷病毒 1 与 2 型;HIV（人类免疫缺陷病毒、人免疫缺陷病毒、艾滋病病毒） 1 型（I 型） 与 2 型（II 型） 人类免疫缺陷病毒 1 与 2 型抗体 人类免疫缺陷病毒 1+2 型 Ab 人类免疫缺陷病毒 1+2 型 Ab.IgG 人类免疫缺陷病毒 1+2 型 IgG 人类免疫缺陷病毒 1+2 型;HIV 1+2 型（人类免疫缺陷病毒 1+2 型、人类免疫缺陷病毒 I+II 型、人免疫缺陷病毒 1+2 型、人免疫缺陷病毒 I+II 型、HIV I+II、HIV I+II 型、艾滋病病毒 I+II 型） 人类免疫缺陷病毒 1+2 型抗体 人类免疫缺陷病毒 1+2 型抗体.IgG 依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型 免疫测定;免疫分析法;免疫检定法;免疫检定;免疫试验;酶免疫测定法;酶免疫测定;酶免疫分析法;酶免疫检定法;酶免疫检定;酶免疫试验 免疫球蛋白 G 存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况（存在、存在与否、是否存在）或阈值（界值、界限、阀值、临界值） 微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体） 时刻;随机;随意;瞬间 血清或血浆

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=40733-8